5G Investment News
  • Top News
  • Economy
  • Forex
  • Investing
  • Stock
  • Editor’s Pick
No Result
View All Result
5G Investment News
  • Top News
  • Economy
  • Forex
  • Investing
  • Stock
  • Editor’s Pick
No Result
View All Result
5G Investment News
No Result
View All Result
Home Stock

Japan medical device maker registers with PEZA

by
July 1, 2024
in Stock
0
Japan medical device maker registers with PEZA
FPIP.COM

JAPANESE medical instrument manufacturer Kaneko Medix, Inc. has registered with the Philippine Economic Zone Authority (PEZA) to operate at an economic zone in Batangas, PEZA said.

In a statement, the investment promotion agency (IPA) said it signed a registration agreement with the Kaneko group’s Philippine unit, which intends to manufacture microcatheters at the First Philippine Industrial Park (FPIP) in Sto. Tomas, Batangas. 

“This agreement marks a significant step forward in the country’s industrial and economic growth, particularly in the medical instrument manufacturing industry,” it added.

The Kaneko project is one of the pledges secured by Director General Tereso O. Panga during the IPA’s investment mission to Tokyo in September 2023.

“The inclusion of Kaneko as one of the locator companies in FPIP emphasizes our commitment to attracting high-tech manufacturing investments and fostering a conducive environment for technological advancement,” PEZA said.

“The establishment of the manufacturing plant in FPIP is expected to significantly contribute to the global supply chain,” it added.

Japanese registered business enterprises (RBEs) overseen by PEZA account for 28% of all approved economic zone investments.

Last year, the IPA’s Japanese RBEs generated more than P500 billion in investments, $16 billion worth of exports, and 300,000 direct jobs. — Justine Irish D. Tabile

Previous Post

MUP pensions, ‘pork’ seen as top targets for reducing deficit

Next Post

OSAPIEA calls bureaucracy in healthcare approval process deterrent to investment 

Next Post
OSAPIEA calls bureaucracy in healthcare approval process deterrent to investment 

OSAPIEA calls bureaucracy in healthcare approval process deterrent to investment 

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.







    Fill Out & Get More Relevant News





    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recommended

    Here’s how your garden grows with Wilcon

    Here’s how your garden grows with Wilcon

    May 16, 2025
    Millennial campaign strategist topples Quezon town’s 33-year dominance

    Millennial campaign strategist topples Quezon town’s 33-year dominance

    May 16, 2025
    Aviva warns against forcing UK pension funds to buy domestic assets

    Aviva warns against forcing UK pension funds to buy domestic assets

    May 16, 2025
    Gold set for steepest weekly drop in six months as trade fears ease and dollar strengthens

    Gold set for steepest weekly drop in six months as trade fears ease and dollar strengthens

    May 16, 2025

    Disclaimer: 5GInvestmentNews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 5GInvestmentNews. All Rights Reserved.

    No Result
    View All Result
    • Home
    • Privacy Policy
    • suspicious engagement
    • Terms & Conditions
    • Thank you

    © 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.